Precise mapping of the replication and transcription promoters of human parainfluenza virus type 3

Virology

Volumn 269, Issue 1, 2000, Pages 201-211

  Hoffman, Michael A ^a   Banerjee, Amiya K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIGNAL PEPTIDE; VIRUS RNA;

ARTICLE; HELA CELL; HUMAN; HUMAN CELL; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; PROMOTER REGION; RNA REPLICATION; RNA TRANSCRIPTION;

HUMAN PARAINFLUENZA VIRUS 3; RNA VIRUSES;

EID: 0034732260     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0223     Document Type: Article

References (35)

1. Abraham G., Rhodes D. P., Banerjee A. K. The 5′ terminal structure of the methylated mRNA synthesized in vitro by vesicular stomatitis virus. Cell. 5:1975;51-58.
2. Belshe R. B., Hissom F. K. Cold adaptation of parainfluenza virus type 3: Induction of three phenotypic markers. J. Med. Virol. 10:1982;235-242.
3. Belshe R. B., Karron R. A., Newman F. K., Anderson E. L., Nugent S. L., Steinhoff M., Clements M. L., Wilson M. H., Hall S. L., Tierney E. L., Murphy B. R. Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children. J. Clin. Microbiol. 30:1992;2064-2070.
4. Calain P., Roux L. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J. Virol. 67:1993;4822-4830.
5. Chuang J. L., Perrault J. Initiation of vesicular stomatitis virus mutant polR1 transcription internally at the N Gene in vitro. J. Virol. 71:1997;1466-1475.
6. Collins P. L., Chanock R. M., McIntosh K. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996a;1205-1241 Lippincott-Raven, Philadelphia.
7. Collins P. L., Hill M. G., Cristina J., Grosfeld H. Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc. Natl. Acad. Sci. USA. 93:1996b;81-85.
8. Das T., Pattnaik A. K., Takacs A. M., Li T., Hwang L. N., Banerjee A. K. Basic amino acid residues at the carboxy-terminal eleven amino acid region of the phosphoprotein (P) are required for transcription but not for replication of vesicular stomatitis virus genome RNA. Virology. 238:1997;103-114.
9. De B. P., Banerjee A. K. Rescue of synthetic analogs of genome RNA of human parainfluenza virus type 3. Virology. 196:1993;344-348.
10. De B. P., Burdsall A. L., Banerjee A. K. Role of cellular actin in human parainfluenza virus type 3 genome transcription. J. Biol. Chem. 268:1993;5703-5710.
11. De B. P., Gupta S., Zhao H., Drazba J. A., Banerjee A. K. Specific interaction in vitro and in vivo of glyceraldehyde-3-phosphate dehydrogenase and LA protein with cis-acting RNA of human parainfluenza virus type 3. J. Biol. Chem. 271:1996;24728-24735.
12. Durbin A. P., Siew J. W., Murphy B. R., Collins P. L. Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of six. Virology. 234:1997;74-83.
13. Egelman E. H., Wu S.-S., Amrein M., Portner A., Murti G. The Sendai virus nucleocapsid exists in at least four different helical states. J. Virol. 63:1989;2233-2243.
14. Hagenbuchle O., Santer M., Steitz J. A. Conservation of the primary structure at the 3′ end of 18S rRNA from Eucaryotic cells. Cell. 13:1978;551-563.
15. Hoffman M. A., Banerjee A. K. An infectious clone of human parainfluenza virus type 3. J. Virol. 71:1997;4272-4277.
16. Juhasz K., Murphy B. R., Collins P. L. The major attenuating mutations of the respiratory syncytial virus vaccine candidate cpts530/1009 specify temperature-sensitive defects in transcription and replication and a non-temperature-sensitive alteration in mRNA termination. J. Virol. 73:1999;5176-5180.
17. Karron R. A., Wright P. F., Newman F. K., Makhene M., Thompson J., Samorodin R., Wilson M. H., Anderson E. L., Clements M. L., Murphy B. R., Belshe R. B. A live human parainfluenza type 3 virus is attenuated and immunogenic in healthy infants and children. J. Infect. Dis. 172:1995;1445-1450.
18. Kolakofsky D., Pelet T., Garcin D., Hausmann S., Curran J., Roux L. Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisted. J. Virol. 72:1998;891-899.
19. Lamb R. A., Kolakofsky D. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;1177-1204 Lippincott-Raven, Philadelphia.
20. Li T., Pattnaik A. K. Replication signals in the genome of vesicular stomatitis virus and its defective interfering particles: Identification of a sequence element that enhances DI RNA replication. Virology. 232:1997;248-259.
21. Li T., Pattnaik A. K. Overlapping signals for transcription and replication at the 3′ terminus of the vesicular stomatitis virus genome. J. Virol. 73:1999;444-452.
22. Murphy S. K., Ito Y., Parks G. D. A functional antigenomic promoter for the paramyxovirus Simian virus 5 requires proper spacing between an essential internal segment and the 3′ terminus. J. Virol. 72:1998;10-19.
23. Murphy S. K., Parks G. D. Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus Simian virus 5. Virology. 232:1997;145-157.
24. Murphy S. K., Parks G. D. RNA replication for the paramyxovirus simian virus 5 requires an internal repeated (GCNNNN) sequence motif. J. Virol. 73:1999;805-809.
25. Peeples M. E., Collins P. L. Mutations in the 5′ trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step. J. Virol. 74:2000;146-155.
26. Perrotta A. T., Been M. D. The pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA. Nature. 350:1991;434-436.
27. Ray R., Meyer K., Newman F. K., Belshe R. B. Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain. J. Virol. 69:1995;1959-1963.
28. Richardson J. C., Peluso R. W. Inhibition of VSV genome RNA replication but not transcription by monoclonal antibodies specific for the viral P protein. Virology. 216:1996;26-34.
29. Samal S. K., Collins P. L. RNA replication by a respiratory syncytial virus RNA analog does not obey the rule of six and retains a nonviral trinucleotide extension at the leader end. J. Virol. 70:1996;5075-5082.
30. Skiadopoulos M. H., Durbin A. P., Tatem J. M., Wu S., Paschalis M., Tao T., Collins P. L., Murphy B. R. Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypes. J. Virol. 72:1998;1762-1768.
31. Tapparel C., Roux L. The efficiency of Sendai virus genome replication: The importance of the RNA primary sequence independent of terminal complementarity. J. Virol. 225:1996;163-171.
32. 3 is essential for replication. J. Virol. 72:1998;3117-3128.
33. Whelan S. P. J., Wertz G. W. Regulation of RNA synthesis by the genomic termini of vesicular stomatitis virus: Identification of distinct sequences essential for transcription but not replication. J. Virol. 73:1999;297-306.
34. Wyatt L. S., Moss B., Rozenblatt S. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology. 210:1995;202-205.
35. Youvan D. C., Hearst J. E. A sequence from Drosophila melanogaster 18S rRNA bearing the conserved hypermodified nucleoside amy analysis by reverse transcription and high-performance liquid chromatography. Nucleic Acids Res. 7:1981;1723-1741.